Biotech

Axios Pro Rata: "Disappointingly limited"

Inside Moderna’s Personalized Cancer Vaccine

Series A activity: Week of August 23, 2026

Data Insight: How often are people infected with malaria?

Axios Pro Rata: FIFA fallout

Axios Pro Rata: Beef bucks

DeepSeek Closes in on Anthropic's Top Model

BREAKING: Inside $12B Colossal Biosciences

From Restoring Sight to Reimagining the Brain, with Max Hodak

Ben Lamm CEO of $12B Colossal Biosciences & $3.8B Astromech

Moderna's Personalized Cancer Vaccine Passes Muster

💰 Agents meet liability

3 killer businesses hiding in plain sight

Chai Discovery's Bitter Lesson: Drug Design Is Another Scaling Problem

Decacorns are the new unicorns

💊 Cheap drugs

Axios Pro Rata: 🦣 Colossal scoop

Zymofix Success Story. 10 OOTB questions to co-founder Emile Redant

Axios Pro Rata: Details matter

Axios Pro Rata: Youngkin's back

Weekly Funding rounds / Statistics / Insights of July 14, 2026

BREAKING: Cyan Banister's Legendary Track Record

Mark Zuckerberg & Priscilla Chan: How AI Will Help Cure Disease

The OWID Brief: Migration data tool, natural disasters, measles vaccines, and more

Weekly TOP Startup / VC news of June 18, 2026

Biohub: The Future of Biology is Open-Source with Co-Founders Mark Zuckerberg, Priscilla Chan, and Head of Science Alex Rives

Who's paying Trump's H-1B fee?

Series A activity: Week of May 31, 2026

SpaceX Aims for a $1.75B Valuation, with Pricing Set for June 11th

Import AI 459: AI oversight is difficult; scaling laws for protein folding models; and pricing the extinction risk…

Biotech IPOs get their groove back

💭 AI's messy middle

Axios Pro Rata: Field of Dumb

The Shift in Global Drug Development

Eli Lilly's $7B hedge against GLP-1s

The Future Of Drug Discovery Is 4 Billion Years Old (Viswa Colluru, Founder & CEO at Enveda)

Frontier labs come for biology

Data Insight: Death rates for cervical cancer in the United Kingdom have fallen by 80% since 1950

Axios Pro Rata: Biotech record-breaker

A race for the wealthy

🏀 Axios Pro Rata: Game on

Anthropic Buys Stealth Dimension-Backed Coefficient Bio in $400M+ Stock Deal

AI for Atoms: How Periodic Labs is Revolutionizing Materials Engineering with Co-Founder Liam Fedus

OpenAI and Anthropic Make Two Very Different Acquisitions

Axios Pro Rata: Here we go

Are Psychedelics the Key to Living Forever? (ft. Bryan Johnson)

Axios Pro Rata: Keytruda corollary

How Autonomous Labs Will Transform Scientific Research: Ginkgo Bioworks’ Jason Kelly

Essentials: Build a Healthy Gut Microbiome | Dr. Justin Sonnenburg

Dave Ricks, CEO of Eli Lilly, on GLP-1s and the business of pharma

140: AI for Science, From the Beginning to Now | Dialogue with Zhang Linfeng and Sun Weijie from DeepWisdom